58.9 F
San Diego
Monday, Mar 18, 2024
-Advertisement-

VentiRx Completes Series A Financing

VentiRx Pharmaceuticals Inc. announced March 6 that it completed $26.6 million in Series A financing to be used to create a portfolio of drug candidates.

San Diego-based VentiRx develops medicines to treat cancer and infectious, respiratory and autoimmune diseases.

Seattle-based Frazier Healthcare Venture, Chicago-based Arch Venture Partners and Princeton, N.J.-based Domain Associates led the round of financing.

Company representatives were appointed to the VentiRx board of directors in connection with the financing.

, Andy Killion

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-